Nonvalvular cardiovascular device-related infections: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{SI}} {{CMG}} ==Overview== ==References== {{Reflist|2}} Category:Cardiology Category:Infectious disease" |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | |||
*[[Pacemaker]]: 0.13% to 19.9% | |||
*[[Defibrillator]]: 0% to 3.2% | |||
*[[LVAD]]: 25% to 70% | |||
*Ventriculoatrial shunt: 2.4% to 9.4% | |||
*Vascular grafts: 1% to 6% | |||
*Intra-aortic balloon pumps: 5% to 26% | |||
*Arterial closure device: 1.9% | |||
*Vena cava filter: rare | |||
*Coronary artery stents: rare | |||
*Peripheral stent: rare | |||
*PDA, ASD, VSD Occlusion device: rare | |||
==References== | ==References== | ||
Revision as of 22:15, 8 October 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
- Pacemaker: 0.13% to 19.9%
- Defibrillator: 0% to 3.2%
- LVAD: 25% to 70%
- Ventriculoatrial shunt: 2.4% to 9.4%
- Vascular grafts: 1% to 6%
- Intra-aortic balloon pumps: 5% to 26%
- Arterial closure device: 1.9%
- Vena cava filter: rare
- Coronary artery stents: rare
- Peripheral stent: rare
- PDA, ASD, VSD Occlusion device: rare